Intraocularis tumorok sugárkezelése Ruthenium-106- tartalmú, bétasugárzó szemészeti applikátorokkal

A. Berta, Damjanovich Judit

Research output: Contribution to journalArticle

Abstract

Aim: Till October 15, 2004, 312 patients were irrradiated with Ruthenium-106-containing ophthalmic applicators at the Department of Ophthalmology, Medical Faculity, University of Debrecen. In this paper we report on experience gained with the irradiation of 187 patients, treated between 1986 and 1999, whose follow-up time interval was at least 5 years. Patients and methods: The distribution according to diagnosis of the patients irradiated between 1986 and 1999 were: choroidal melanoma 148, retinoblastoma 15, retinal angioma 9, carcinoma metastasis 4, subretinal neovascularization 11. The instruments purchased from the German Bebig firm were sutured under surgical circumstances onto the sclera, and were removed from the eye with another operation. The applied dose calculated to the inner surface of the tumors was 100 Gy in the case of choroidal melanomas, and 50 Gy in the case of retinoblastomas. Results: From the patients irradiated because of malignant intraocular tumors 154 (95.7%) were evaluated. From the evaluated patients 148 (96.1%) are alive. Among the living patients 4 (2.7%) is suffering from distant metastasis. From the irradiated eyes 148 (96.1%) could be saved. Six eyes had to be enucleated, 1 eye because of phthisis bulbi, 2 because of hemorrhagic glaucoma, and 3 because of uncontrollable tumor growth. Discussion: With the help of radioactive isotope-containing applicators the intraocular malignant tumors can be distroyed, so that the eyes can be saved with useful vision, without risking the patients' life.

Original languageHungarian
Pages (from-to)53-57
Number of pages5
JournalMagyar Onkologia
Volume49
Issue number1
Publication statusPublished - 2005

ASJC Scopus subject areas

  • Oncology

Cite this

Intraocularis tumorok sugárkezelése Ruthenium-106- tartalmú, bétasugárzó szemészeti applikátorokkal. / Berta, A.; Judit, Damjanovich.

In: Magyar Onkologia, Vol. 49, No. 1, 2005, p. 53-57.

Research output: Contribution to journalArticle

@article{1d07c76e443148f3bca88a595bace479,
title = "Intraocularis tumorok sug{\'a}rkezel{\'e}se Ruthenium-106- tartalm{\'u}, b{\'e}tasug{\'a}rz{\'o} szem{\'e}szeti applik{\'a}torokkal",
abstract = "Aim: Till October 15, 2004, 312 patients were irrradiated with Ruthenium-106-containing ophthalmic applicators at the Department of Ophthalmology, Medical Faculity, University of Debrecen. In this paper we report on experience gained with the irradiation of 187 patients, treated between 1986 and 1999, whose follow-up time interval was at least 5 years. Patients and methods: The distribution according to diagnosis of the patients irradiated between 1986 and 1999 were: choroidal melanoma 148, retinoblastoma 15, retinal angioma 9, carcinoma metastasis 4, subretinal neovascularization 11. The instruments purchased from the German Bebig firm were sutured under surgical circumstances onto the sclera, and were removed from the eye with another operation. The applied dose calculated to the inner surface of the tumors was 100 Gy in the case of choroidal melanomas, and 50 Gy in the case of retinoblastomas. Results: From the patients irradiated because of malignant intraocular tumors 154 (95.7{\%}) were evaluated. From the evaluated patients 148 (96.1{\%}) are alive. Among the living patients 4 (2.7{\%}) is suffering from distant metastasis. From the irradiated eyes 148 (96.1{\%}) could be saved. Six eyes had to be enucleated, 1 eye because of phthisis bulbi, 2 because of hemorrhagic glaucoma, and 3 because of uncontrollable tumor growth. Discussion: With the help of radioactive isotope-containing applicators the intraocular malignant tumors can be distroyed, so that the eyes can be saved with useful vision, without risking the patients' life.",
author = "A. Berta and Damjanovich Judit",
year = "2005",
language = "Hungarian",
volume = "49",
pages = "53--57",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - Intraocularis tumorok sugárkezelése Ruthenium-106- tartalmú, bétasugárzó szemészeti applikátorokkal

AU - Berta, A.

AU - Judit, Damjanovich

PY - 2005

Y1 - 2005

N2 - Aim: Till October 15, 2004, 312 patients were irrradiated with Ruthenium-106-containing ophthalmic applicators at the Department of Ophthalmology, Medical Faculity, University of Debrecen. In this paper we report on experience gained with the irradiation of 187 patients, treated between 1986 and 1999, whose follow-up time interval was at least 5 years. Patients and methods: The distribution according to diagnosis of the patients irradiated between 1986 and 1999 were: choroidal melanoma 148, retinoblastoma 15, retinal angioma 9, carcinoma metastasis 4, subretinal neovascularization 11. The instruments purchased from the German Bebig firm were sutured under surgical circumstances onto the sclera, and were removed from the eye with another operation. The applied dose calculated to the inner surface of the tumors was 100 Gy in the case of choroidal melanomas, and 50 Gy in the case of retinoblastomas. Results: From the patients irradiated because of malignant intraocular tumors 154 (95.7%) were evaluated. From the evaluated patients 148 (96.1%) are alive. Among the living patients 4 (2.7%) is suffering from distant metastasis. From the irradiated eyes 148 (96.1%) could be saved. Six eyes had to be enucleated, 1 eye because of phthisis bulbi, 2 because of hemorrhagic glaucoma, and 3 because of uncontrollable tumor growth. Discussion: With the help of radioactive isotope-containing applicators the intraocular malignant tumors can be distroyed, so that the eyes can be saved with useful vision, without risking the patients' life.

AB - Aim: Till October 15, 2004, 312 patients were irrradiated with Ruthenium-106-containing ophthalmic applicators at the Department of Ophthalmology, Medical Faculity, University of Debrecen. In this paper we report on experience gained with the irradiation of 187 patients, treated between 1986 and 1999, whose follow-up time interval was at least 5 years. Patients and methods: The distribution according to diagnosis of the patients irradiated between 1986 and 1999 were: choroidal melanoma 148, retinoblastoma 15, retinal angioma 9, carcinoma metastasis 4, subretinal neovascularization 11. The instruments purchased from the German Bebig firm were sutured under surgical circumstances onto the sclera, and were removed from the eye with another operation. The applied dose calculated to the inner surface of the tumors was 100 Gy in the case of choroidal melanomas, and 50 Gy in the case of retinoblastomas. Results: From the patients irradiated because of malignant intraocular tumors 154 (95.7%) were evaluated. From the evaluated patients 148 (96.1%) are alive. Among the living patients 4 (2.7%) is suffering from distant metastasis. From the irradiated eyes 148 (96.1%) could be saved. Six eyes had to be enucleated, 1 eye because of phthisis bulbi, 2 because of hemorrhagic glaucoma, and 3 because of uncontrollable tumor growth. Discussion: With the help of radioactive isotope-containing applicators the intraocular malignant tumors can be distroyed, so that the eyes can be saved with useful vision, without risking the patients' life.

UR - http://www.scopus.com/inward/record.url?scp=84875041951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875041951&partnerID=8YFLogxK

M3 - Article

C2 - 15902335

AN - SCOPUS:84875041951

VL - 49

SP - 53

EP - 57

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 1

ER -